These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 15282385

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I, Hall IP, McFarlane LC, Lipworth BJ.
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ, Winter TH, Aalbers R.
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [Abstract] [Full Text] [Related]

  • 5. Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.
    Lee DK, Jackson CM, Currie GP, Cockburn WJ, Lipworth BJ.
    Br J Clin Pharmacol; 2003 Nov; 56(5):494-500. PubMed ID: 14651722
    [Abstract] [Full Text] [Related]

  • 6. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
    Haney S, Hancox RJ.
    Respir Res; 2005 Sep 16; 6(1):107. PubMed ID: 16168062
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
    Bleecker ER, Yancey SW, Baitinger LA, Edwards LD, Klotsman M, Anderson WH, Dorinsky PM.
    J Allergy Clin Immunol; 2006 Oct 16; 118(4):809-16. PubMed ID: 17030231
    [Abstract] [Full Text] [Related]

  • 10. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM, Boulet LP, Follows RM.
    Clin Ther; 2005 Apr 16; 27(4):393-406. PubMed ID: 15922813
    [Abstract] [Full Text] [Related]

  • 11. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.
    Bleecker ER, Postma DS, Lawrance RM, Meyers DA, Ambrose HJ, Goldman M.
    Lancet; 2007 Dec 22; 370(9605):2118-25. PubMed ID: 18156033
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the relative efficacy of formoterol and salmeterol in asthmatic patients.
    Palmqvist M, Ibsen T, Mellén A, Lötvall J.
    Am J Respir Crit Care Med; 1999 Jul 22; 160(1):244-9. PubMed ID: 10390407
    [Abstract] [Full Text] [Related]

  • 13. Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD.
    Partridge MR, Schuermann W, Beckman O, Persson T, Polanowski T.
    Ther Adv Respir Dis; 2009 Aug 22; 3(4):1-11. PubMed ID: 19734176
    [Abstract] [Full Text] [Related]

  • 14. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar 22; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the bronchodilating effects of inhaled formoterol, salmeterol and salbutamol in asthmatic patients.
    Grembiale RD, Pelaia G, Naty S, Vatrella A, Tranfa CM, Marsico SA.
    Pulm Pharmacol Ther; 2002 Mar 22; 15(5):463-6. PubMed ID: 12406669
    [Abstract] [Full Text] [Related]

  • 16. Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism.
    Lipworth BJ, Dempsey OJ, Aziz I.
    Chest; 2000 Aug 22; 118(2):321-8. PubMed ID: 10936119
    [Abstract] [Full Text] [Related]

  • 17. Inhaled steroid/long-acting beta 2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients.
    Lötvall J, Langley S, Woodcock A.
    Respir Res; 2006 Aug 18; 7(1):110. PubMed ID: 16919161
    [Abstract] [Full Text] [Related]

  • 18. Salbutamol tolerance to bronchoprotection: course of onset.
    Stewart SL, Martin AL, Davis BE, Cockcroft DW.
    Ann Allergy Asthma Immunol; 2012 Dec 18; 109(6):454-7. PubMed ID: 23176887
    [Abstract] [Full Text] [Related]

  • 19. Effects of adding a leukotriene antagonist or a long-acting beta(2)-agonist in asthmatic patients with the glycine-16 beta(2)-adrenoceptor genotype.
    Lipworth BJ, Dempsey OJ, Aziz I, Wilson AM.
    Am J Med; 2000 Aug 01; 109(2):114-21. PubMed ID: 10967152
    [Abstract] [Full Text] [Related]

  • 20. Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics.
    Tan S, Hall IP, Dewar J, Dow E, Lipworth B.
    Lancet; 1997 Oct 04; 350(9083):995-9. PubMed ID: 9329515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.